Tokyo Wellness Impact Fund Invests in HICKY Inc., Developer of a Treatment Device for Central Sleep Apnea
NQ Score
42/100
N1 Content Completeness
4
AI Summary (NQ-processed)
The Tokyo Wellness Impact Fund, which practices impact investing, has announced its investment in HICKY Inc. HICKY is developing an innovative medical device to treat Central Sleep Apnea (CSA), a condition that worsens the prognosis for heart failure patients. This investment supports a technology aiming to improve outcomes for this patient population.